# A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.

> **NCT05619328** · PHASE3 · COMPLETED · sponsor: **Procter and Gamble** · enrollment: 323 (actual)

## Conditions studied

- Peripheral Sensory Neuropathy of Different Etiologies

## Interventions

- **DRUG:** Vitamin B combination tablet
- **DRUG:** Placebo Tablet

## Key facts

- **NCT ID:** NCT05619328
- **Lead sponsor:** Procter and Gamble
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-06
- **Primary completion:** 2023-11-02
- **Final completion:** 2023-11-02
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05619328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05619328, "A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05619328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*